Evidence map›Paper›PMID 41083104›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2026

Enhancing SARS-CoV-2 response capacity in Africa and other centers for research in emerging infectious diseases centres through a collaborative training programme.

Ambroise Ahouidi, Abdou Padane, Alioune Gaye, Anavaj Sakuntabha, Awa Deme, Badara Cisse, Carla de Oliveira, Caroline Weldon, Cyrille Diedhiou, Daouda Ndiaye and 18 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Ambroise AhouidiInstitut De Recherche En Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal.
Abdou PadaneInstitut De Recherche En Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal.
Alioune GayeInstitut Pasteur, Dakar, Senegal.
Anavaj SakuntabhaInstitut Pasteur, Paris, France; Ecology and Emergence of Arthropod-Borne Pathogens Unit, Institut Pasteur, Centre National de la Researche Scientifique Unite Mixte de Reserche2000, Paris, France.
Awa DemeUniversite Cheikh Anta Diop (UCAD), Dakar, Senegal.
Badara CisseInstitut De Recherche En Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal.
Carla de OliveiraLaboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.
Caroline WeldonInstitute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Cyrille DiedhiouInstitut De Recherche En Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal.
Daouda NdiayeUniversite Cheikh Anta Diop (UCAD), Dakar, Senegal.
Geoffrey S GottliebDepartments of Medicine and Global Health, Environmental Health & Safety Department Division of Allergy & Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington, Seattle, WA, USA.
Helene McOwenCenter for Emerging and Reemerging Infectious Diseases (CERID), Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Ibrahima DiaInstitut Pasteur, Dakar, Senegal.
Joilson XavierInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Katherine J SiddleBroad Institute of Massachusetts Institute of Technology & Harvard, Cambridge, MA, USA.
Kristian AndersenScripps Research Institute, La Jolla, CA, USA.
Lynn BarrettCenter for Emerging and Reemerging Infectious Diseases (CERID), Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Mariétou Faye PayeBroad Institute of Massachusetts Institute of Technology & Harvard, Cambridge, MA, USA.
Mawlouth DialloInstitut Pasteur, Dakar, Senegal.
Sasha TillesCenter for Emerging and Reemerging Infectious Diseases (CERID), Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Scott C WeaverInstitute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Shirlee WohlScripps Research Institute, La Jolla, CA, USA.
Tulio de OliveiraCentre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch, South Africa.
Luiz Carlos Junior AlcantaraInstituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.
Wesley C Van VoorhisCenter for Emerging and Reemerging Infectious Diseases (CERID), Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Souleymane MboupInstitut De Recherche En Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal.
Eduan WilkinsonCentre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch, South Africa.
Marta GiovanettiDepartment of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address: giovanetti.marta@gmail.com.

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
NIAID NIH HHS U01 AI151698
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AfricaCapacity buildingGenomic surveillanceSARS-CoV-2Training programme

Identifiers

PMID41083104
PMCPMC13179709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.